Sorrento Therapeutics Inc
SRNE·Stocks·Biotechnology·United States·OTC Markets Stock Exchange·USD
Price
$0.07
Today
+0.0%
YTD
+2700.0%
About
Sorrento Therapeutics is a biopharmaceutical firm based in San Diego, California. Operating internationally, the company was founded in 2006 and designs treatments for autoimmune and cancer-related diseases, among others. Its stock fell in 2020 when the firm’s Chief Financial Officer was dismissed. It is listed on the NASDAQ CM using the ticker SRNE. Find the latest SRNE price chart information at eToro.
Price chart
Closing price history for SRNE (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)0.00
P/S (TTM)0.03
P/B (TTM)-0.01
Market cap$385,900.00
Cap tierMicro-cap
Industry avg P/E-6.22
Profitability
Gross margin37.55%
EBIT margin-553.17%
Net margin-633.69%
ROE-1329.41%
ROA-100.68%
Earnings & Revenue
Revenue (TTM)$64.27M
Revenue growth (1Y)+16.9%
EPS (TTM)-$1.06
Free cash flow$-243.21M
Total debt$207.60M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)-1.61
Employees949
Next earnings22 Nov '23
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.